The specific aim of this project is on the renovation of the fourth floor of Faser Hall and 5000 gross square feet of new laboratory space on the third and fourth floors of Faser Hall in order to improve the capability of The University of Mississippi to support a burgeoning, cutting-edge biomedical research program. At the foundation of this program are a number of PHS-funded research projects to discover, design, and synthesize new drugs for unmet therapeutic needs in human health, an important national priority. The School of Pharmacy Building named Faser Hall was completed and occupied in May, 1969. Faser Hall has been the location of the research endeavors of the Pharmaceutical Sciences for nearly thirty years. While some renovation and repairs have occurred over this time, the current structure and infrastructure is quite antiquated for conducting contemporary, state-of-the-art biomedical research. Expansive research growth has occurred during this period making the laboratories more crowded. The University of Mississippi School of Pharmacy has undertaken a long-term and comprehensive plan to totally renovate Faser Hall. This will result in increased research space, more efficient use of research space, and an enhancement of the laboratories to meet contemporary safety standards. The State of Mississippi and the University have provided $2,000,000 for the development of a comprehensive planning strategy for the replacement of the roof and significant infrastructure changes including the renovation of the fourth floor and for new construction of 5000 gross square of new laboratory space designated as """"""""swing space"""""""" which will become permanent research facilities for the third and fourth floors. Current projects and personnel will be moved into this swing space while renovation occurs in Faser Hall, thus greatly minimizing disruption to active biomedical research. This request is for $1.0 million of total funds from NIH to match with State funds to achieve complete renovation of the research laboratories on the entire fourth floor of Faser Hall and construction of additional research space on the third and fourth floors. The fourth floor currently houses the Drug Discovery, Design and Synthesis Research Program which as significant current and pending NIH grants. This unit encompasses a number of important therapeutic areas (including AIDS and associated opportunistic infections, cancer, malaria, contraception, cardiovascular disease, treatment of cocaine and heroin addiction, immune-mediated diseases). The current laboratories are small and crowded, and contain relatively few hoods, most of which are small and marginally functional; a research environment which is less than ideal for the quality research being conducted. Completion of the renovation as planned for the fourth floor and the construction of laboratories extended from the third and fourth floors will greatly increase the usable space and provide contemporary and safer laboratories for conducting biomedical research.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Research Facilities Construction Grant (C06)
Project #
1C06RR014503-01
Application #
6039588
Study Section
Scientific and Technical Review Board on Biomedical and Behavioral Research Facilities (STRB)
Program Officer
Mccullough, Willie
Project Start
1999-09-30
Project End
2004-09-29
Budget Start
1999-09-30
Budget End
2004-09-29
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Mississippi
Department
Type
Schools of Pharmacy
DUNS #
City
University
State
MS
Country
United States
Zip Code
38677
Larit, Farida; Elokely, Khaled M; Chaurasiya, Narayan D et al. (2018) Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants. Phytomedicine 40:27-36
Tarawneh, Amer H; Al-Momani, Lo Ay A; León, Francisco et al. (2018) Evaluation of Triazole and Isoxazole Derivatives as Potential Anti-infective Agents. Med Chem Res 27:1269-1275
Larit, Farida; Nael, Manal A; Benyahia, Samira et al. (2018) Secondary metabolites from the aerial parts of Cytisus villosus Pourr. Phytochem Lett 24:1-5
Pandey, Pankaj; Chaurasiya, Narayan D; Tekwani, Babu L et al. (2018) Interactions of endocannabinoid virodhamine and related analogs with human monoamine oxidase-A and -B. Biochem Pharmacol 155:82-91
Pressly, Jeffrey D; Mustafa, Suni M; Adibi, Ammaar H et al. (2018) Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury. J Pharmacol Exp Ther 364:287-299
Oh, Joonseok; Liu, Haining; Park, Hyun Bong et al. (2017) In silico investigation of lavandulyl flavonoids for the development of potent fatty acid synthase-inhibitory prototypes. Biochim Biophys Acta Gen Subj 1861:3180-3188
Wang, Xiaojuan; Liu, Jiabao; Pandey, Pankaj et al. (2017) Assignment of the absolute configuration of hepatoprotective highly oxygenated triterpenoids using X-ray, ECD, NMR J-based configurational analysis and HSQC overlay experiments. Biochim Biophys Acta Gen Subj 1861:3089-3095
Chaurasiya, Narayan D; León, Francisco; Ding, Yuanqing et al. (2017) Interactions of Desmethoxyyangonin, a Secondary Metabolite from Renealmia alpinia, with Human Monoamine Oxidase-A and Oxidase-B. Evid Based Complement Alternat Med 2017:4018724
Mostafa, Ahmad E; El-Hela, Atef A; Mohammad, Abd-Elsalam I et al. (2016) New triterpenoidal saponins fromKoelreuteria paniculata. Phytochem Lett 17:213-218
Mohammed, Noorullah Naqvi; Pandey, Pankaj; Khan, Nayaab S et al. (2016) Clotrimazole-cyclodextrin based approach for the management and treatment of Candidiasis - A formulation and chemistry-based evaluation. Pharm Dev Technol 21:619-29

Showing the most recent 10 out of 129 publications